Ignite Creation Date:
2024-05-06 @ 12:49 AM
Last Modification Date:
2024-10-26 @ 10:55 AM
Study NCT ID:
NCT01667536
Status:
COMPLETED
Last Update Posted:
2017-02-07
First Post:
2012-08-13
Brief Title:
A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology
Sponsor:
Molecular Insight Pharmaceuticals Inc
Organization:
Molecular Insight Pharmaceuticals Inc
Organization Data
Organization:
Molecular Insight Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
MIP-1404-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Molecular Insight Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None